- Home
- BBIO vs NIO Comparison
BBIO vs NIO Comparison
Compare BBIO & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- NIO
- Stock Information
- Founded
- BBIO 2015
- NIO 2014
- Country
- BBIO United States
- NIO China
- Employees
- BBIO N/A
- NIO N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- NIO Auto Manufacturing
- Sector
- BBIO Health Care
- NIO Consumer Discretionary
- Exchange
- BBIO Nasdaq
- NIO Nasdaq
- Market Cap
- BBIO 7.6B
- NIO 8.1B
- IPO Year
- BBIO 2019
- NIO 2018
- Fundamental
- Price
- BBIO $41.73
- NIO $3.41
- Analyst Decision
- BBIO Strong Buy
- NIO Hold
- Analyst Count
- BBIO 13
- NIO 7
- Target Price
- BBIO $56.67
- NIO $4.90
- AVG Volume (30 Days)
- BBIO 2.5M
- NIO 33.6M
- Earning Date
- BBIO 07-31-2025
- NIO 06-03-2025
- Dividend Yield
- BBIO N/A
- NIO N/A
- EPS Growth
- BBIO N/A
- NIO N/A
- EPS
- BBIO N/A
- NIO N/A
- Revenue
- BBIO $127,415,000.00
- NIO $9,351,292,224.00
- Revenue This Year
- BBIO $102.05
- NIO $39.75
- Revenue Next Year
- BBIO $54.69
- NIO $26.49
- P/E Ratio
- BBIO N/A
- NIO N/A
- Revenue Growth
- BBIO N/A
- NIO 23.71
- 52 Week Low
- BBIO $21.62
- NIO $3.02
- 52 Week High
- BBIO $41.90
- NIO $7.71
- Technical
- Relative Strength Index (RSI)
- BBIO 69.82
- NIO 36.71
- Support Level
- BBIO $39.65
- NIO $3.49
- Resistance Level
- BBIO $41.36
- NIO $3.90
- Average True Range (ATR)
- BBIO 1.51
- NIO 0.13
- MACD
- BBIO 0.35
- NIO -0.02
- Stochastic Oscillator
- BBIO 97.37
- NIO 9.65
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About NIO NIO Inc. American depositary shares each representing one ordinary share
Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.